{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:04:06Z","timestamp":1760731446707,"version":"3.44.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ejphar.2021.174065","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T17:51:30Z","timestamp":1616781090000},"page":"174065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Central and peripheral emetic loci contribute to vomiting evoked by the Akt inhibitor MK-2206 in the least shrew model of emesis"],"prefix":"10.1016","volume":"900","author":[{"given":"Weixia","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seetha","family":"Chebolu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0028-099X","authenticated-orcid":false,"given":"Nissar A.","family":"Darmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174065_bib1","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/s41416-018-0242-3","article-title":"Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of humancolorectal and prostate carcinoma","volume":"119","author":"Al-Saffar","year":"2018","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejphar.2021.174065_bib2","first-page":"130","article-title":"Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting","volume":"1","author":"Aziz","year":"2012","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.ejphar.2021.174065_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2013.08.047","article-title":"The role of vagal neurocircuits in the regulation of nausea and vomiting","volume":"722","author":"Babic","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174065_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062478","article-title":"Histone acetylation-mediated regulation of the Hippo pathway","volume":"8","author":"Basu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2021.174065_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178593","article-title":"A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solidtumors","volume":"12","author":"Becher","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2021.174065_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pharmthera.2016.12.001","article-title":"Maximising the potential of AKT inhibitors as anti-cancer treatments","volume":"172","author":"Brown","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2021.174065_bib7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/cne.902960402","article-title":"Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat","volume":"296","author":"Bullitt","year":"1990","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2021.174065_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejphar.2009.11.030","article-title":"Pranlukast prevents cysteinyl leukotriene-induced emesis in the least shrew (Cryptotis parva)","volume":"628","author":"Chebolu","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174065_bib9","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jamaoncol.2016.5383","article-title":"Effect of selumetinib and MK-2206 vs oxaliplatin and fluorouracil in patients with metastatic pancreatic cancer after prior therapy: SWOG S1115 study randomized clinical trial","volume":"3","author":"Chung","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ejphar.2021.174065_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1074-5521(00)00025-9","article-title":"Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription","volume":"7","author":"Coghlan","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejphar.2021.174065_bib11","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s007020050118","article-title":"Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis","volume":"105","author":"Darmani","year":"1998","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.ejphar.2021.174065_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pbb.2004.10.019","article-title":"Delta-9-tetrahydrocannabinol differentially suppresses emesis versus enhanced locomotor activity produced by chemically diverse dopamine D2\/D3 receptor agonists in the least shrew (Cryptotis parva)","volume":"80","author":"Darmani","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2021.174065_bib13","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1021\/cr900117p","article-title":"Evidence for a re-evaluation of the neurochemical and anatomical bases of chemotherapy-induced vomiting","volume":"109","author":"Darmani","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejphar.2021.174065_bib14","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s007020050222","article-title":"The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew)","volume":"106","author":"Darmani","year":"1999","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.ejphar.2021.174065_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejphar.2007.01.093","article-title":"Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew","volume":"563","author":"Darmani","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174065_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brainres.2008.03.077","article-title":"Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1receptor antagonists","volume":"1214","author":"Darmani","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2021.174065_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brainres.2008.10.063","article-title":"A re-evaluation of the neurotransmitter basis of chemotherapy-induced immediate and delayed vomiting: evidence from the least shrew","volume":"1248","author":"Darmani","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2021.174065_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejphar.2013.08.052","article-title":"Broad-spectrum antiemetic potential of the L-type calcium channel antagonist nifedipine and evidence for its additive antiemetic interaction with the 5-HT(3) receptor antagonist palonosetron in the least shrew (Cryptotis parva)","volume":"722","author":"Darmani","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174065_bib20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pbb.2015.02.010","article-title":"Differential and additive suppressive effects of 5-HT3 (palonosetron)- and NK1 (netupitant)-receptor antagonists on cisplatin-induced vomiting and ERK1\/2, PKA and PKC activation","volume":"131","author":"Darmani","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2021.174065_bib21","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/nmo.12371","article-title":"Distinct subcellular localization of the neuronal marker HuC\/D reveals hypoxia-induced damage in enteric neurons","volume":"26","author":"Desmet","year":"2014","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.ejphar.2021.174065_bib22","doi-asserted-by":"crossref","first-page":"8967","DOI":"10.1158\/0008-5472.CAN-09-2190","article-title":"Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy","volume":"69","author":"Fu","year":"2009","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejphar.2021.174065_bib23","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1007\/s00018-020-03543-6","article-title":"Functional circuits and signal processing in the enteric nervous system","volume":"77","author":"Fung","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2021.174065_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-1838(00)00127-2","article-title":"Types of neurons in the enteric nervous system","volume":"81","author":"Furness","year":"2000","journal-title":"J. Auton. Nerv. Syst."},{"key":"10.1016\/j.ejphar.2021.174065_bib25","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1113\/jphysiol.2009.170852","article-title":"Na(V)-igating excitement in the enteric nervous system","volume":"587","author":"Galligan","year":"2009","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2021.174065_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/mol.104.009092","article-title":"Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution","volume":"68","author":"Garcia","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174065_bib27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11912-009-0016-4","article-title":"Perifosine: update on a novel Akt inhibitor","volume":"11","author":"Gills","year":"2009","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.ejphar.2021.174065_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0031-6997(25)06867-X","article-title":"Calcium antagonism and calcium entry blockade","volume":"38","author":"Godfraind","year":"1986","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2021.174065_bib29","doi-asserted-by":"crossref","first-page":"17541","DOI":"10.1073\/pnas.1905902116","article-title":"Akt phosphorylation of neuronal nitric oxide synthase regulates gastrointestinal motility in mouse ileum","volume":"116","author":"Guerra","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2021.174065_bib30","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1182\/blood-2005-08-3434","article-title":"Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells","volume":"107","author":"Hideshima","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2021.174065_bib31","doi-asserted-by":"crossref","first-page":"47366","DOI":"10.1074\/jbc.M208284200","article-title":"U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells","volume":"277","author":"Hotokezaka","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.174065_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0014-2999(01)00936-0","article-title":"Effect of dopamine D2\/D3 receptor antagonist sulpiride on amphetamine-induced changes in striatal extracellular dopamine","volume":"418","author":"Jaworski","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174065_bib33","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1007\/s12094-018-1888-2","article-title":"Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial","volume":"20","author":"Kalinsky","year":"2018","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.ejphar.2021.174065_bib34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10637-006-6406-7","article-title":"A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: a National Cancer Institute of Canada Clinical Trials Group trial","volume":"24","author":"Knowling","year":"2006","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.ejphar.2021.174065_bib35","first-page":"1093","article-title":"Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation","volume":"2","author":"Kondapaka","year":"2003","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejphar.2021.174065_bib36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/aur.2109","article-title":"Colonic dilation and altered ex vivo gastrointestinal motility in the neuroligin-3 knockout mouse","volume":"13","author":"Leembruggen","year":"2020","journal-title":"Autism Res."},{"key":"10.1016\/j.ejphar.2021.174065_bib38","doi-asserted-by":"crossref","first-page":"E173","DOI":"10.1210\/jc.2011-1054","article-title":"The Akt inhibitor MK2206 synergizes, but perifosine antagonizes, the BRAF(V600E) inhibitor PLX4032 and the MEK1\/2 inhibitor AZD6244 in the inhibition of thyroid cancer cells","volume":"97","author":"Liu","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2021.174065_bib39","first-page":"124","article-title":"Targeting Akt by SC66 triggers GSK-3\u03b2 mediated apoptosis in colon cancer therapy","volume":"19","author":"Liu","year":"2019","journal-title":"Canc. Cell Int."},{"key":"10.1016\/j.ejphar.2021.174065_bib40","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1158\/1078-0432.CCR-17-1260","article-title":"A phase II trial of neoadjuvant MK-2206, an AKT inhibitor, with anastrozole in clinical stage II or III PIK3CA-mutant ER-positive and HER2-negative breast cancer","volume":"23","author":"Ma","year":"2017","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejphar.2021.174065_bib41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2021.174065_bib42","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1158\/1078-0432.CCR-17-0725","article-title":"A first-time-in-human study of GSK2636771, a phosphoinositide 3 kinase beta-selective inhibitor, in patients with advanced solid tumors","volume":"23","author":"Mateo","year":"2017","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejphar.2021.174065_bib43","first-page":"1476","article-title":"Kinase inhibitors of HER2\/AKT pathway induce ERK phosphorylation via a FOXO-dependent feedback loop","volume":"7","author":"Matkar","year":"2017","journal-title":"Am. J. Canc. Res."},{"key":"10.1016\/j.ejphar.2021.174065_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/diseases7010022","article-title":"Roles of PI3K\/AKT\/GSK3 pathway involved in psychiatric illnesses","volume":"7","author":"Matsuda","year":"2019","journal-title":"Diseases"},{"key":"10.1016\/j.ejphar.2021.174065_bib45","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.neuroscience.2012.09.020","article-title":"Glycogen synthase kinase 3-specific inhibitor AR-A014418 decreases neuropathic pain in mice: evidence for the mechanisms of action","volume":"226","author":"Mazzardo-Martins","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2021.174065_bib46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbcan.2018.08.001","article-title":"The next generation of PI3K-Akt-mTOR pathway inhibitors in breast cancer cohorts","volume":"1870","author":"McKenna","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.ejphar.2021.174065_bib47","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00726-014-1736-9","article-title":"Involvement of substance P and the NK-1 receptor in human pathology","volume":"46","author":"Mu\u00f1oz","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejphar.2021.174065_bib48","doi-asserted-by":"crossref","first-page":"e1107","DOI":"10.1038\/tp.2017.56","article-title":"Effects of dopamine D2\/D3 receptor antagonism on human planning and spatial working memory","volume":"7","author":"Naef","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejphar.2021.174065_bib49","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40265-013-0019-1","article-title":"Management of chemotherapy-induced nausea and vomiting: focus on newer agents and new uses for older agents","volume":"73","author":"Navari","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2021.174065_bib50","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s11894-010-0129-9","article-title":"Enteric nervous system in the small intestine: pathophysiology and clinical implications","volume":"12","author":"Nezami","year":"2010","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.ejphar.2021.174065_bib51","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3892\/ijo.2015.3306","article-title":"Akt inhibitors in cancer treatment: the long journey from drug discovery to clinical use (Review)","volume":"48","author":"Nitulescu","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2021.174065_bib52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gene.2019.02.076","article-title":"The relation between PI3K\/AKT signalling pathway and cancer","volume":"698","author":"Noorolyai","year":"2019","journal-title":"Gene"},{"issue":"Suppl. 10","key":"10.1016\/j.ejphar.2021.174065_bib53","doi-asserted-by":"crossref","first-page":"x21","DOI":"10.1093\/annonc\/mdz440","article-title":"Management of toxicity to isoform \u03b1-specific PI3K inhibitors","volume":"30","author":"Nunnery","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejphar.2021.174065_bib54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2016.11.030","article-title":"The GABAB positive allosteric modulators CGP7930 and GS39783 stimulate ERK1\/2 signalling in cells lacking functional GABAB receptors","volume":"794","author":"Olianas","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174065_bib55","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/BJ20140826","article-title":"Akt-mediated regulation of antidepressant-sensitive serotonin transporter function, cell-surface expression and phosphorylation","volume":"468","author":"Rajamanickam","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2021.174065_bib56","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/cncr.29363","article-title":"Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: a SWOG cooperative group trial (S1005)","volume":"121","author":"Ramanathan","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ejphar.2021.174065_bib57","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pbb.2009.08.010","article-title":"Receptor-selective agonists induce emesis and Fos expression in the brain and enteric nervous system of the least shrew (Cryptotis parva)","volume":"94","author":"Ray","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2021.174065_bib58","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00401-009-0549-5","article-title":"The reactions of specific neuron types to intestinal ischemia in the Guinea pig enteric nervous system","volume":"118","author":"Rivera","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejphar.2021.174065_bib59","doi-asserted-by":"crossref","first-page":"2 6","DOI":"10.1016\/j.ejphar.2013.08.049","article-title":"Molecular mechanisms of 5-HT(3) and NK(1) receptor antagonists in prevention of emesis","volume":"722","author":"Rojas","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174065_bib60","series-title":"Management of Nausea and Vomiting in Cancer and Cancer Treatment","first-page":"15","article-title":"Mechanisms of acute, delayed and anticipatory vomiting in cancer and cancer treatment","author":"Rudd","year":"2004"},{"key":"10.1016\/j.ejphar.2021.174065_bib61","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3389\/fphar.2016.00263","article-title":"Profile of antiemetic activity of netupitant alone or in combination with palonosetron and dexamethasone in ferrets and suncus murinus (house musk shrew)","volume":"7","author":"Rudd","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174065_bib62","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1038\/onc.2010.626","article-title":"PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer","volume":"30","author":"Serra","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2021.174065_bib63","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1021\/cn100031t","article-title":"Akt-dependent and isoform-specific regulation of dopamine transporter cell surface expression","volume":"1","author":"Speed","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174065_bib64","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/BJ20110040","article-title":"Next-generation Akt inhibitors provide greater specificity: effects on glucose metabolism in adipocytes","volume":"435","author":"Tan","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2021.174065_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2007.01.016","article-title":"Calcium channel antagonists: clinical uses--past, present and future","volume":"74","author":"Triggle","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174065_bib66","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00418-005-0019-7","article-title":"Cytoplasmic, but not nuclear, expression of the neuronal nuclei (NeuN) antibody is an exclusive feature of Dogiel type II neurons in the Guinea-pig gastrointestinal tract","volume":"124","author":"Van Nassauw","year":"2005","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2021.174065_bib67","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tips.2013.07.005","article-title":"Mechanisms of dopamine transporter regulation in normal and disease states","volume":"34","author":"Vaughan","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2021.174065_bib68","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/cne.21872","article-title":"J Expression and developmental regulation of oxytocin (OT) and oxytocin receptors (OTR) in the enteric nervous system (ENS) and intestinal epithelium","volume":"512","author":"Welch","year":"2009","journal-title":"Comp. Neurol."},{"key":"10.1016\/j.ejphar.2021.174065_bib69","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1200\/JCO.2011.35.5263","article-title":"First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors","volume":"29","author":"Yap","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2021.174065_bib70","doi-asserted-by":"crossref","first-page":"104603","DOI":"10.1016\/j.neuint.2019.104603","article-title":"The pivotal role of glycogen synthase kinase 3 (GSK-3) in vomiting evoked by specific emetogens in the least shrew (Cryptotis parva)","volume":"132","author":"Zhong","year":"2020","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2021.174065_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104718","article-title":"Serotonin 5-HT3 receptor-mediated vomiting occurs via the activation of Ca2+\/CaMKII-dependent ERK1\/2 signaling in the least shrew (Cryptotis parva)","volume":"9","author":"Zhong","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2021.174065_bib72","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2015.11.023","article-title":"Thapsigargin-induced activation of Ca(2+)-CaMKII-ERK in brainstem contributes to substance P release and induction of emesis in the least shrew","volume":"103","author":"Zhong","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2021.174065_bib73","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.autneu.2016.07.006","article-title":"Ca2+ signaling and emesis: recent progress and new perspectives","volume":"202","author":"Zhong","year":"2017","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174065_bib74","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejphar.2018.06.035","article-title":"Intracellular emetic signaling evoked by the L-type Ca2+ channel agonist FPL64176 in the least shrew (Cryptotis parva)","volume":"834","author":"Zhong","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174065_bib75","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuint.2018.11.012","article-title":"Intracellular emetic signaling cascades by which the selective neurokinin type 1 receptor (NK1R) agonist GR73632 evokes vomiting in the least shrew (Cryptotis parva)","volume":"122","author":"Zhong","year":"2019","journal-title":"Neurochem. Int."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921002181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921002181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:49:33Z","timestamp":1757976573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921002181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":73,"alternative-id":["S0014299921002181"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174065","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central and peripheral emetic loci contribute to vomiting evoked by the Akt inhibitor MK-2206 in the least shrew model of emesis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"174065"}}